| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 02/26/2004 | US20040038263 Method of isolating secretion signals in lactic acid bacteria and novel secretion signals isolated from lactococcus lactis |
| 02/26/2004 | US20040038257 Therapeutic peptidase for diagnosis, treatment and prevention of cancer and nervous system disorders |
| 02/26/2004 | US20040038250 Isolating, purifying and cloning multicistronic nucleotide sequences coding polypeptides associated with biosynthesis and expression of thienamycin; rational drug design and screening |
| 02/26/2004 | US20040038244 Comprises expression vector capable of chromosomal insertion and transcription of telomerase for generating transgenic somatic cells and screening and/or identifying antitumor and anticarcinogenic agents |
| 02/26/2004 | US20040038238 Comprises chimeric membrane proteins for diagnosis, treatment and prevention of inflammation, cancer, metabolic, gastrointestinal and autoimmune disorders |
| 02/26/2004 | US20040038236 Mutation associated with epilepsy |
| 02/26/2004 | US20040038235 A g-protein coupled receptor |
| 02/26/2004 | US20040038230 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038223 Comprise polypeptide for diagnosis, prevention and treatment of cardiomyopathy, atherosclerosis, hypertension, cancer, diabetes and nervous system disorders |
| 02/26/2004 | US20040038213 Genotyping by in situ PCR amplification of a polynucleotide in a tissue biopsy |
| 02/26/2004 | US20040038209 Comprises nucleotide sequences coding beta -carotene dioxygenase which cleaves beta carotene and produces vitamin a aldehyde; improving nutritional value of plants, microorganisms and animal feeds |
| 02/26/2004 | US20040038203 Comprises nucleotide sequences coding yaba monkey tumor viral protein for treatment and prevention of autoimmune diseases |
| 02/26/2004 | US20040037849 Vaccines for cat scratch fever |
| 02/26/2004 | US20040037846 Chlamydia pmp proteins, gene sequences and uses thereof |
| 02/26/2004 | US20040037841 Nucleic acid sequences that are expressed in chondrocytes from fetal, normal, mild osteoarthritic, moderate osteoarthritic, marked and osteoarthritic |
| 02/26/2004 | US20040037833 Comprises purified imunoglobulin polypeptide or antigen binding fragment for diagnosis of disease/cancer |
| 02/26/2004 | US20040037829 For immunoregulation and/or treatment of inflammation; muteins |
| 02/26/2004 | US20040036976 Apparatus for using optical tweezers to manipulate materials |
| 02/26/2004 | DE10237517A1 Removing biomolecules from liquid media, useful for purification, product recovery or preparation of vectors, comprises retention on hydrotalcite of controlled porosity |
| 02/26/2004 | DE10225139A1 Verfahren zur Identifizierung von immunreaktiven Peptiden A method for identifying immunoreactive peptides |
| 02/26/2004 | CA2535760A1 Apicomplexan pathways, inhibitiors, and drug delivery |
| 02/26/2004 | CA2496437A1 Improved methods of in vitro protein synthesis |
| 02/26/2004 | CA2495185A1 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 02/26/2004 | CA2495177A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 02/26/2004 | CA2494971A1 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 02/26/2004 | CA2492932A1 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 02/26/2004 | CA2492524A1 Humanized rabbit antibodies |
| 02/25/2004 | EP1391518A1 Process for producing peptide |
| 02/25/2004 | EP1391516A1 Von willebrand factor (vwf)-cleaving enzyme |
| 02/25/2004 | EP1391515A1 Process for producing coenzyme q 10 |
| 02/25/2004 | EP1391513A1 IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof |
| 02/25/2004 | EP1391510A1 Method of constructing host and process for producing foreign protein |
| 02/25/2004 | EP1391502A1 Host microorganisms |
| 02/25/2004 | EP1390744A2 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression |
| 02/25/2004 | EP1390543A2 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 02/25/2004 | EP1390540A1 Chemically assembled nano-scale circuit elements |
| 02/25/2004 | EP1390521A1 Glycopeptide antibiotics |
| 02/25/2004 | EP1390519A2 Microorganisms and processes for enhanced production of pantothenate |
| 02/25/2004 | EP1390516A1 Novel expression vectors and uses thereof |
| 02/25/2004 | EP1390506A1 A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same |
| 02/25/2004 | EP1390505A2 Antigens of group b streptococcus and corresponding dna fragments |
| 02/25/2004 | EP1390504A2 Nucleotide sequences which code for the metd gene |
| 02/25/2004 | EP1390502A2 Interferon-alpha induced gene |
| 02/25/2004 | EP1390499A2 Cell visual characteristic-modifying sequences |
| 02/25/2004 | EP1390496A2 Glutamate receptor modulatory proteins and nucleic acids encoding them |
| 02/25/2004 | EP1390490A2 Muscle-specific expression vectors |
| 02/25/2004 | EP1390483A2 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene |
| 02/25/2004 | EP1390470A2 Production of alpha-lipoic acid |
| 02/25/2004 | EP1390468A2 Identification of essential genes of aspegillus fumigatus and methods of use |
| 02/25/2004 | EP1390410A1 Molecules for disease detection and treatment |
| 02/25/2004 | EP1390404A2 Interleukin-1 related gene and protein |
| 02/25/2004 | EP1390402A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/25/2004 | EP1390397A1 Pre-s protein of hepatitis b virus (hbv) as an adjuvant and a component of hbv vaccine |
| 02/25/2004 | EP1390394A2 Compositions and methods for recombinational cloning of nucleic acid molecules |
| 02/25/2004 | EP1390392A1 Methods to inhibit viral replication |
| 02/25/2004 | EP1390391A1 Transporters and ion channels |
| 02/25/2004 | EP1390071A2 Symbiotic regenerative agent |
| 02/25/2004 | EP1390057A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and method of use |
| 02/25/2004 | EP0981620B1 Hgf polypeptides and their use in therapy |
| 02/25/2004 | EP0877818B1 Process for activating a kinase |
| 02/25/2004 | EP0866861B1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 02/25/2004 | EP0820515B1 Phospholipase c homolog |
| 02/25/2004 | EP0759987B1 Antibody against human restrictin |
| 02/25/2004 | EP0749478B1 Yeast strains and modified albumins |
| 02/25/2004 | CN2604441Y Apparatus for producing high-absorbance rhodophyll with Helminthocladiaceae |
| 02/25/2004 | CN1478144A Production process and composition of an enzymatic preparation and its use for treatment of domestic and industrial effluents of high fat, protein and/or carbohydrate content |
| 02/25/2004 | CN1478097A Method and cell for detecting modulations of RGS proteins |
| 02/25/2004 | CN1477969A Chemokine mutants in treatment of multiple sclerosis |
| 02/25/2004 | CN1477203A Method for preparing optical pure phenylethanediol by utilizing microbial stereoselectivity transformation and its special-purpose microbe |
| 02/25/2004 | CN1477200A High-effective aciduric liquifying saccharifyig enzyme, its preparation method and application |
| 02/25/2004 | CN1477189A Strain for food preservation and its anti-bacterial product |
| 02/25/2004 | CN1139660C WK-5344A and WK-5344D substances and their producing |
| 02/24/2004 | US6696620 Immunoglobulin binding protein arrays in eukaryotic cells |
| 02/24/2004 | US6696295 Transducing phages |
| 02/24/2004 | US6696293 Process for producing carotenoids and biological materials useful therefor |
| 02/24/2004 | US6696282 Fusarium sporotrichioides strains for production of lycopene |
| 02/24/2004 | US6696279 Modulating methionine adenosyltransferase ii (mat ii) catalytic activity |
| 02/24/2004 | US6696270 Gastric submucosal tissue as a novel diagnostic tool |
| 02/24/2004 | US6696257 G protein-coupled receptors from the rat and human |
| 02/24/2004 | US6696254 Detection and identification of enteric bacteria |
| 02/24/2004 | US6696251 Selection of sequences with desirable binding properties |
| 02/24/2004 | US6696062 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 02/24/2004 | US6696019 High and low pressure cycles |
| 02/21/2004 | CA2437664A1 Anti-aging/menopause symptoms relief using ganoderma lucidum spores |
| 02/20/2004 | CA2437473A1 Method for preservation of cells and nucleic acid targets |
| 02/19/2004 | WO2004015125A1 Process for preparing peptides with anti-hypertensive properties |
| 02/19/2004 | WO2004015114A2 Heterologous expression system comprising a b. subtilis promoter |
| 02/19/2004 | WO2004015113A2 Albumin-fused ciliary neurotrophic factor |
| 02/19/2004 | WO2004015110A1 Sugar chain synthase gene |
| 02/19/2004 | WO2004015109A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use |
| 02/19/2004 | WO2004015103A1 Akt2-BINDING PROTEIN |
| 02/19/2004 | WO2004015099A2 Vaccine composition comprising lipooligosaccharide with reduced phase variability |
| 02/19/2004 | WO2004015057A2 Mucin-immunoglobulin fusion proteins |
| 02/19/2004 | WO2004014419A1 Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria |
| 02/19/2004 | WO2004014418A2 Neisserial vaccine compositions comprising a combination of antigens |
| 02/19/2004 | WO2004014417A2 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis |
| 02/19/2004 | WO2004014403A1 Microorganisms for inhibiting obesity and diabetes mellitus |
| 02/19/2004 | WO2004014311A2 Nogo receptor antagonists |
| 02/19/2004 | WO2004014295A2 Tiacumicin production |
| 02/19/2004 | WO2004007726A3 Brachyspira hyodysenteriae vaccine |